SUMMIT, N.J.–(BUSINESS WIRE)–Concord Health Partners, a healthcare focused investment firm, announced today that Tim Leahy has joined the firm as a Managing Director on the investment team.
Mr. Leahy is an experienced investment professional with over two decades of healthcare industry investing experience. He previously served as a Managing Director at BelHealth Investment Partners, a healthcare focused buyout firm, where he focused on originating, structuring, and executing private equity transactions in healthcare services and medical products, specifically in the provider and medical technology industries.
Prior to BelHealth, Mr. Leahy spent 19 years at Goldman Sachs, having joined the firm in 1999. He most recently served as a Managing Director and Portfolio Manager at Goldman Sachs Asset Management where he was a senior member of a multi-strategy team with $15+ billion of assets under management. Mr. Leahy had analytical and investing oversight of a variety of healthcare sub-sectors including healthcare services, health insurance, medical devices, health technology, diagnostics and life science tools. Prior to joining the Asset Management division, Mr. Leahy was a research analyst on a highly ranked team, as noted by Institutional Investor All-America surveys, covering healthcare services within the Global Investment Research Division at Goldman Sachs.
“I am thrilled to join the team at Concord and excited be part of a firm looking to accelerate innovation across healthcare. Concord’s pioneering approach to engagement between healthcare investors and portfolio companies is uniquely positioned in the market. I firmly believe Concord’s strategic model will hasten improvements throughout the health care ecosystem and create significant value for investors and portfolio companies,” said Mr. Leahy.
“We are pleased to welcome Tim to the Concord team. He is an accomplished investment professional, having spent 20+ years developing and executing investment strategies across healthcare. Tim’s public and private equity investment experience will be a tremendous asset to our firm as we look to make investments in healthcare companies that reduce costs and improve quality,” said James Olsen, Founder & Managing Partner at Concord.
About Concord Health Partners
Concord Health Partners is a healthcare-focused investment firm with a strategic approach that aligns interests between investors and portfolio companies. Concord is primarily focused on investing in companies that have the potential to enhance the value of care through technologies and solutions that lower costs, improve quality and/or expand access to care.
For more information, please contact James Olsen at Concord Health Partners at info@concordhp.com or 212-508-7090. Please visit Concord’s website at www.concordhp.com.
Contacts
James Olsen
www.concordhp.com
Concord Health Partners
info@concordhp.com
212-508-7090
Government and industry have tried and failed to stem the overdose epidemic for more than…
Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Post-Traumatic Stress…
eClinicalWorks successfully completes UDS+ FHIR® synthetic testing and begins FQHC voluntary testingWESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the…
Report Reveals Key Factors Shaping the Healthcare Recruitment and Retention LandscapeNEW YORK, NY / ACCESSWIRE…
Sustained acoustic medicine technology from ZetrOZ Systems eliminates veteran's severe knee pain without surgery or…
Halifax, Nova Scotia--(Newsfile Corp. - March 25, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB:…
